Jatin is a Client Partner at Prescient and has been with the company since 2014. He holds a Master’s degree in Biotechnology from the University of Manchester and has worked in the pharmaceutical analysis divisions of several major organizations, including Bloomberg. At Prescient, Jatin has directed multiple global projects across a range of domains, including immunology, oncology, hematology, neurology, nephrology, endocrinology, respiratory disease and biosimilars. He applies his broad experience across functions and his strategic mindset to a variety of engagement types, such as commercial strategy development workshops and intelligence-driven consultative projects.
Featured
Connecting Insights to Strategy
Read the article to discover leadership perspectives on how connected customer intelligence, strategic expertise and AI support better brand decisions.
News and insights
Featured
Strategy That Learns: Rethinking Brand Planning for a Changing Environment
Read the article to discover leadership perspectives on how connected customer intelligence, strategic expertise and AI support better brand decisions.
From Data-Rich to Decision-Ready
Discover why earlier, faster integration of integrated insights are a strategic imperative and now matter more than ever.
ONWARD: Driving Equitable Access and System Readiness in Cancer Care
This Dolon Institute paper highlights six interconnected barriers affecting timely access to oncology innovation, drawing on examples from healthcare systems around the world.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
